Full Text View
Tabular View
No Study Results Posted
Related Studies
Total Temporomandibular Joint Replacement System Post Approval Study
This study has been completed.
First Received: September 26, 2008   Last Updated: September 29, 2008   History of Changes
Sponsored by: Biomet, Inc.
Information provided by: Biomet, Inc.
ClinicalTrials.gov Identifier: NCT00762944
  Purpose

Post-Approval Study (PMA CoA) in Order to Obtain Additional Long Term Safety and Effectiveness Data


Condition
Arthroplasty

Study Type: Observational
Study Design: Cohort, Prospective
Official Title: Total Temporomandibular Joint Replacement System Post Approval Study

Further study details as provided by Biomet, Inc.:

Primary Outcome Measures:
  • jaw pain intensity (VAS score), interference with eating, mouth opening [ Time Frame: 3 yr ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • jaw pain intensity (VAS score), interference with eating, mouth opening [ Time Frame: 1yr, 1.5yr ] [ Designated as safety issue: No ]
  • Patient Satisfaction [ Time Frame: 6m, 1 yr, 1.5 yr, and 3 yr ] [ Designated as safety issue: No ]

Biospecimen Retention:   None Retained

Biospecimen Description:

Enrollment: 92
Study Start Date: September 2005
Study Completion Date: September 2008
Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients who received TMJ systems from the IDE study

Criteria

Inclusion Criteria:

  1. Patients requiring total joint reconstruction due to:

    Arthritis (osteo-, rheumatoid, traumatic) malignancy Ankylosis functional deformity Avascular necrosis revisions Benign neoplasms fracture Multiple operated joints

  2. Patients who are skeletally mature.
  3. Patients must have at least one of the following criteria for surgical TMJ treatment.

    1. Presence of considerable pain and/or limited function in the joint area.
    2. Clinical and imaging evidence consistent with anatomic joint pathology
    3. Previous failure of non-surgical treatment/therapy or a failed implant.
    4. High probability of patient improvement by surgical treatment.
  4. Patients must be able to return for follow-up examinations.
  5. Patients without serious compromising general medical conditions.

Exclusion Criteria:

  1. Patients with active infection.
  2. Patient conditions where there is insufficient quantity or quality of bone to support the device
  3. Patients with perforations in the mandibular fossa and/or bony deficiencies in the articular eminence compromising support for the artificial fossa component.
  4. Patients with mandibular and/or zygomatic arch screw holes compromising component fixation
  5. Patients requiring partial joint reconstruction or other TMJ procedures not listed as an indication.
  6. Patients who are NOT skeletally mature.
  7. Patients who are incapable or unwilling to follow postoperative care instructions.
  8. Patients who are unable to return for follow-up examinations.
  9. Patients with severe hyper-functional habits
  10. Patients on chronic steroid therapy.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00762944

Locations
United States, Indiana
Riley Hospital
Indianapolis, Indiana, United States
United States, Michigan
Jeffrey S. Topf, D.D.S.
West Bloomfield, Michigan, United States
United States, Pennsylvania
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
United States, Texas
The University of Texas,Southwestern Medical School
Dallas, Texas, United States
Sponsors and Collaborators
Biomet, Inc.
Investigators
Study Director: Kim Reed Biomet Microfixation
  More Information

No publications provided

Responsible Party: Biomet Microfixation ( Kim Reed, Regulatory Affairs Manager )
Study ID Numbers: BMET WL 01
Study First Received: September 26, 2008
Last Updated: September 29, 2008
ClinicalTrials.gov Identifier: NCT00762944     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by Biomet, Inc.:
Patients requiring total joint reconstruction due to:
Arthritis (osteo-, rheumatoid, traumatic) malignancy
Ankylosis functional deformity
Avascular necrosis revisions
Benign neoplasms fracture
Multiple operated joints

Study placed in the following topic categories:
Necrosis
Osteonecrosis
Arthritis
Fractures, Bone
Congenital Abnormalities
Ankylosis

ClinicalTrials.gov processed this record on September 11, 2009